Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Knowledge transfer and implications for R&D and innovation in pharmaceutical companies after the acquisition of a biotechnology company

Publication

Knowledge transfer and implications for R&D and innovation in pharmaceutical companies after the acquisition of a biotechnology company

Schweizer, Lars (2004): Knowledge transfer and implications for R&D and innovation in pharmaceutical companies after the acquisition of a biotechnology company, in: M. K. Weaver (Hrsg.), Conference proceedings, Chicago.

Details

Faculty/Chair
Author
Schweizer, Lars
Title of the compilation
Conference proceedings
Editors
Weaver, M. K.
Corporate Body
Academy of Management
Year of publication
2004
Language
English
Type
Conferenceobject
URI
Activation date
2014-09-24, 2014-09-24

Permalink: https://fis.uni-bamberg.de/handle/uniba/13033 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.